<DOC>
	<DOC>NCT00169221</DOC>
	<brief_summary>This trial will be an open multicentric randomized phase II study comparing post-operative radiotherapy + cisplatin associated or not with Iressa in upper aerodigestive tract carcinomas.</brief_summary>
	<brief_title>Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients with upper aerodigestive tract carcinomas (all sites included) having surgical resection and eligible for postoperative radiation + cisplatin. Patient having a tumoral biopsy (0.5 1 cm3) stored in liquid nitrogen at time of surgical resection (patients with small tumors located in larynx for instance will not be included) Patients receiving postoperative radiation (&gt;=60 Gy on tumor bed and/or cervical area), associated with cisplatin, 6 weeks after surgery at the latest. previous history of cancer (except skin basal cell carcinoma)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>